Maternal Medicine
-
Prenatal PFAS Exposure Linked to Long-Term Maternal Metabolic Risks, EU Studies Reveal
New research shows prenatal PFAS exposure increases maternal insulin resistance and beta-cell dysfunction, with EU regulators proposing stricter limits as clinical trials explore interventions. June…
-
Prenatal PFAS exposure linked to long-term maternal diabetes risk through beta cell dysfunction, new study finds
A May 2024 cohort study reveals prenatal PFAS exposure reduces maternal beta cell function by 15-20%, increasing diabetes risk. EU proposals and NIH funding highlight…